← Leaderboards
Frances E Jensen
Children'S Hospital Boston
$20,656,904
Attributed
$27,184,106
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,872,582 · 15
By mechanism
R01$8,442,325 · 3
DP1$4,203,138 · 1
P20$3,224,950 · 2
T32$2,958,508 · 1
R37$2,757,026 · 1
P01$2,227,687 · 1
Top collaborators
- Basil T Darras7 shared
- Jerome None Engel7 shared
- David A Hovda7 shared
- Asla Sl Pitkanen7 shared
- Scott Loren Pomeroy7 shared
- Takao K Hensch6 shared
- Marc A Dichter5 shared
- Geoffrey Karl Aguirre4 shared
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Paul A Rosenberg$14,149,755
- Hannah C Kinney$8,853,075
Others in their field
Top investigators on “Epilepsy”
- Karen Wilcox · University Of Utah$40,784,208
- Mark J Daly · Broad Institute, Inc.$39,233,325
- Wayne N. Frankel · Jackson Laboratory$37,394,025
- Shlomo Shinnar · Montefiore Medical Center (Bronx, Ny)$34,999,274
- Christopher A Walsh · Beth Israel Deaconess Medical Center$34,874,606
- Stacey Gabriel · Massachusetts Institute Of Technology$34,637,180
Research focus
EpilepsySeizuresBrainGlutamate ReceptorTranslationsNeuronsPreventAlzheimer&AposLifeEpileptogenesisInnovationImpaired CognitionSignal PathwayFundingPreventionIn VivoCellsSignal TransductionHuman TissueProgramsAntiepileptic AgentsSynapsesAnimalsMolecular
Grant awards (77)
Seizure-induced enhancement of synaptic signaling regulating tau transmissibility in Alzheimer's Disease$686,422
R01 · FY2025 · AG · contact PI
Tracking the evolution of synaptic dysplasticity after early life seizures$542,182
R37 · FY2025 · NS · contact PI
Seizure-induced enhancement of synaptic signaling regulating tau transmissibility in Alzheimer's Disease$712,374
R01 · FY2024 · AG · contact PI
Tracking the evolution of synaptic dysplasticity after early life seizures$602,423
R37 · FY2024 · NS · contact PI
Remapping Clinical Neuroscience through Translation and Innovation Training (ReCoNnecT-IT)$1
T32 · FY2024 · NS · contact PI
Seizure-induced enhancement of synaptic signaling regulating tau transmissibility in Alzheimer's Disease$720,618
R01 · FY2023 · AG · contact PI
Remapping Clinical Neuroscience through Translation and Innovation Training (ReCoNnecT-IT)$579,234
T32 · FY2023 · NS · contact PI
Seizure-induced enhancement of synaptic signaling regulating tau transmissibility in Alzheimer's Disease$673,961
R01 · FY2022 · AG · contact PI
Remapping Clinical Neuroscience through Translation and Innovation Training (ReCoNnecT-IT)$327,692
T32 · FY2022 · NS · contact PI
Remapping Clinical Neuroscience through Translation and Innovation Training (ReCoNnecT-IT)$373,723
T32 · FY2021 · NS · contact PI
Tracking the evolution of synaptic dysplasticity after early life seizures$1,612,421
R37 · FY2020 · NS · contact PI
Remapping Clinical Neuroscience through Translation and Innovation Training (ReCoNnecT-IT)$461,908
T32 · FY2020 · NS · contact PI
Remapping neurology through translation and innovation$261,891
T32 · FY2019 · NS
Interaction between epilepsy and AD: novel therapeutic strategies$201,250
R21 · FY2019 · NS · contact PI
Remapping neurology through translation and innovation$307,572
T32 · FY2018 · NS
Interaction between epilepsy and AD: novel therapeutic strategies$241,500
R21 · FY2018 · NS · contact PI
NINDS NEXT: Children's Hospital Boston Clinical Research Site$346,954
U10 · FY2017 · NS
Remapping neurology through translation and innovation$293,506
T32 · FY2017 · NS
Early Life Seizures Disrupt Critical Period Plasticity$411,265
R01 · FY2016 · NS · contact PI
NINDS NEXT: Children's Hospital Boston Clinical Research Site$347,142
U10 · FY2016 · NS
Remapping neurology through translation and innovation$215,438
T32 · FY2016 · NS
Early Life Seizures Disrupt Critical Period Plasticity$413,020
R01 · FY2015 · NS · contact PI
NINDS NEXT: Children's Hospital Boston Clinical Research Site$258,489
U10 · FY2015 · NS
Remapping neurology through translation and innovation$137,543
T32 · FY2015 · NS
Early Life Seizures Disrupt Critical Period Plasticity$135,045
R01 · FY2015 · NS · contact PI
The Epilepsy Bioinformatics Study (EpiBioS)$605,805
P20 · FY2014 · NS
Exploratory Grant Program in Disease Modification and Prevention in the Epilepsi$605,803
P20 · FY2014 · NS
Early Life Seizures Disrupt Critical Period Plasticity$409,568
R01 · FY2014 · NS · contact PI
NINDS NEXT: Children's Hospital Boston Clinical Research Site$343,556
U10 · FY2014 · NS
Early Life Seizures Disrupt Critical Period Plasticity$2,237
R01 · FY2014 · NS · contact PI
The Epileptogenic Effect of Perinatal Hypoxia$484,685
R56 · FY2013 · NS · contact PI
The Epilepsy Bioinformatics Study (EpiBioS)$446,019
P20 · FY2013 · NS
Exploratory Grant Program in Disease Modification and Prevention in the Epilepsi$446,019
P20 · FY2013 · NS
Early Life Seizures Disrupt Critical Period Plasticity$429,559
R01 · FY2013 · NS · contact PI
NINDS NEXT: Children's Hospital Boston Clinical Research Site$237,612
U10 · FY2013 · NS
The NKCC1 inhibitor bumetanide as a novel therapy in TSC$187,918
R21 · FY2013 · NS · contact PI
The Epilepsy Bioinformatics Study (EpiBioS)$152,000
P20 · FY2013 · NS
The Epilepsy Bioinformatics Study (EpiBioS)$484,652
P20 · FY2012 · NS
Exploratory Grant Program in Disease Modification and Prevention in the Epilepsi$484,652
P20 · FY2012 · NS
NINDS NEXT: Children's Hospital Boston Clinical Research Site$339,500
U10 · FY2012 · NS
The NKCC1 inhibitor bumetanide as a novel therapy in TSC$249,675
R21 · FY2012 · NS · contact PI
CH/BIDMC/Harvard Medical School Neurology Resident Research Education Program$117,766
R25 · FY2012 · NS · contact PI
Understanding the Cognitive Impact of Early Life Epilepsy$584,695
DP1 · FY2011 · OD · contact PI
The Epileptogenic Effect of Perinatal Hypoxia$362,294
R01 · FY2011 · NS · contact PI
NINDS NEXT: Children's Hospital Boston Clinical Research Site$344,369
U10 · FY2011 · NS
Understanding the Cognitive Impact of Early Life Epilepsy$238,443
DP1 · FY2011 · OD · contact PI
CH/BIDMC/Harvard Medical School Neurology Resident Research Education Program$75,600
R25 · FY2011 · NS · contact PI
CH/BIDMC/Harvard Medical School Neurology Resident Research Education Program$1
R25 · FY2011 · NS · contact PI
Understanding the Cognitive Impact of Early Life Epilepsy$845,000
DP1 · FY2010 · OD · contact PI
Attenuating the retinal and CNS adverse effects of vigabatrin with NKCC1 inhibito$404,735
RC1 · FY2010 · NS · contact PI
The Epileptogenic Effect of Perinatal Hypoxia$365,991
R01 · FY2010 · NS · contact PI
CH/BIDMC/Harvard Medical School Neurology Resident Research Education Program$46,920
R25 · FY2010 · NS · contact PI
Understanding the Cognitive Impact of Early Life Epilepsy$845,000
DP1 · FY2009 · OD · contact PI
Attenuating the retinal and CNS adverse effects of vigabatrin with NKCC1 inhibito$408,776
RC1 · FY2009 · NS · contact PI
The Epileptogenic Effect of Perinatal Hypoxia$369,688
R01 · FY2009 · NS · contact PI
Mechanisms of Excitotoxic Injury to Developing Oligodendrocytes$253,560
P01 · FY2009 · NS · contact PI
The Epileptogenic Effect of Perinatal Hypoxia$111,670
R01 · FY2009 · NS · contact PI
Understanding the Cognitive Impact of Early Life Epilepsy$845,000
DP1 · FY2008 · OD · contact PI
The Epileptogenic Effect of Perinatal Hypoxia$369,688
R01 · FY2008 · NS · contact PI
Mechanisms of Excitotoxic Injury to Developing Oligodendrocytes$253,560
P01 · FY2008 · NS · contact PI
Understanding the Cognitive Impact of Early Life Epilepsy$845,000
DP1 · FY2007 · OD · contact PI
The Epileptogenic Effect of Perinatal Hypoxia$422,500
R56 · FY2007 · NS · contact PI
Mechanisms of Excitotoxic Injury to Developing Oligodendrocytes$314,771
P01 · FY2007 · NS · contact PI
The Epileptogenic Effect of Perinatal Hypoxia$326,957
R01 · FY2006 · NS · contact PI
Mechanisms of Excitotoxic Injury to Oligodendrocytes$312,887
P01 · FY2006 · NS · contact PI
The Epileptogenic Effect of Perinatal Hypoxia$334,825
R01 · FY2005 · NS
Mechanisms of Excitotoxic Injury to Oligodendrocytes$308,513
P01 · FY2005 · NS
The Epileptogenic Effect of Perinatal Hypoxia$334,825
R01 · FY2004 · NS
The Epileptogenic Effect of Perinatal Hypoxia$47,142
R01 · FY2004 · NS
The Epileptogenic Effect of Perinatal Hypoxia$334,825
R01 · FY2003 · NS
The Epileptogenic Effect of Perinatal Hypoxia$334,825
R01 · FY2002 · NS
Excitotoxic injury to developing oligodendrocytes$196,099
P01 · FY2002 · NS
EPILEPTOGENIC EFFECT OF PERINATAL HYPOXIA$269,334
R01 · FY2001 · NS
Excitotoxic injury to developing oligodendrocytes$196,099
P01 · FY2001 · NS
EPILEPTOGENIC EFFECT OF PERINATAL HYPOXIA$286,192
R01 · FY2000 · NS
Excitotoxic injury to developing oligodendrocytes$196,099
P01 · FY2000 · NS
Excitotoxic injury to developing oligodendrocytes$196,099
P01 · FY2000 · NS